Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BIOPHTA Logo
BIOPHTA Growth Score
86
CB Rank
84625
Heat Score
3
BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.
Founded
obfuscation
PrivateSeed Paris, Ile-de-France, France1-10 www.biophta.com
Biotechnology
Health Care
Medical Device
Overview

BIOPHTA
Total Funding
obfuscation
Growth Score
86
Heat Score
3

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score86
-3 pts
in past quarter
Heat Score 3
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BIOPHTA

CB Rank
84625
BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.
Founded
obfuscation
PrivateSeed Paris, Ile-de-France, France1-10 www.biophta.com
Biotechnology
Health Care
Medical Device

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Bioadhesive Ophthalmics
Operating Status Active
Company Type For Profit
Founders  Jean Cuiné, Jean Garrec
About the Company
BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
Contact Email contact@biophta.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Ophthalmic Inserts
A 3mm mini-tablet placed on the eye surface that transforms into a hydrogel to deliver continuous, controlled low-dose drug release for 7 days.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed
obfuscation
Seed Round - BIOPHTA Logo
Seed Round - BIOPHTA
5
obfuscation
Elaia, GO CAPITAL, UI InvestissementSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News

News and Press

News•Jun 4, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

146
14.06%
 in past month

Active Website Tech Count

2BIOPHTA is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 10m.

Total IP

2The intellectual property of BIOPHTA includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is BIOPHTA's headquarters? BIOPHTA is located in Paris, Ile-de-France, France.Who invested in BIOPHTA? BIOPHTA has 5 investors including Unither Pharmaceuticals and  Elaia.When was the last funding round for BIOPHTA? BIOPHTA closed its last funding round on
obfuscation
from a Seed round.Who are BIOPHTA's competitors? Alternatives and possible competitors to BIOPHTA may include Bausch & Lomb, NicOx, and  KALA BIO.How much funding has BIOPHTA raised to date? BIOPHTA has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|